BIO and the Indiana Health Industry Forum commend Indiana Governor, Mike Pence for signing legislation designed to create pathway for substitution of interchangeable biologic medicines. Policies outlined in Senate Bill 262 align with all 5 of BIO’s principles on biologic substitution. Bill seeks to properly preserve patient access to accurate prescription information, maintains incentives for innovation, and promotes competitive market for biologic therapies.
This story is related to the following:Trade Associations